David Henry (@davidhenrymd) 's Twitter Profile
David Henry

@davidhenrymd

Hematologist Oncologist🩸 | Vice Chair Dept of Medicine Pennsylvania Hospital | Blood&Cancer host Research-supportive care @MDedgeTweets @MDedgeHemeOnc

ID: 2358545944

linkhttps://www.pennmedicine.org/providers/profile/david-henry calendar_today22-02-2014 12:40:58

1,1K Tweet

2,2K Takipçi

3,3K Takip Edilen

David Henry (@davidhenrymd) 's Twitter Profile Photo

Adjuvant #Pertuzumab May Improve Overall Survival For Patients With HER2-Positive, Node-Positive #BreastCancer MDedge Hematology & Oncology medscape.com/viewarticle/ad…

David Henry (@davidhenrymd) 's Twitter Profile Photo

Improving Outcomes➡️Addition of #Niraparib for metastatic, hormone-sensitive prostate cancer with HRR gene alterations may slow progression MDedge Hematology & Oncology #ProstateCancer medscape.com/viewarticle/ad…

David Henry (@davidhenrymd) 's Twitter Profile Photo

Potential improvements in complete response rates using Sintilimab with standard treatment regimen for #HodgkinLymphoma MDedge Hematology & Oncology medscape.com/viewarticle/hl…

David Henry (@davidhenrymd) 's Twitter Profile Photo

#GallbladderCancer and #Cholangiocarcinoma: Improved outcomes with use of #Camrelizumab as part of triple therapy medscape.com/viewarticle/ad…

David Henry (@davidhenrymd) 's Twitter Profile Photo

Study found that #Itacitinib use prior to immune effector cell therapy resulted in decreased incidence of cytokine release syndrome MDedge Hematology & Oncology medscape.com/viewarticle/ca…

David Henry (@davidhenrymd) 's Twitter Profile Photo

Phase 3 Trial finds that Ivonescimab improves progression free survival for patients with EGFR-mutated non-small cell lung cancer MDedge Hematology & Oncology medscape.com/viewarticle/bi…

David Henry (@davidhenrymd) 's Twitter Profile Photo

Study found no difference in quality of life and side effects between radiation and proton therapies in #OropharyngealCancer MDedge Hematology & Oncology medscape.com/viewarticle/pr…